New Jersey Receives Over $11 Million in Funding to Access Opioid Treatment Services, Including Medication-Assisted Treatment
The U.S. Department of Health and Human Services (HHS) has released an additional $487 million for the State Opioid Response (SOR) grant program. New Jersey received $11,257,470 in supplemental funding. This program and funding supports states efforts to expand access to opioid treatment services, especially medication-assisted treatment (MAT) with appropriate social supports. The awards are part of HHS’s Five-Point Opioid Strategy.
This is the first of two expected grant announcements. The total grants will send nearly $1.5 billion in SOR funds to the states for FY 2019. SOR funds are distributed to the states based upon a formula that considers the unmet need for opioid use disorder treatment and drug overdose deaths in each state.
“One year ago this week, President Trump launched his national opioid initiative, which called for expanding access to compassionate, evidence-based treatment, including MAT. This week’s funding awards to states were possible because of legislation Congress passed and President Trump signed since then,” said HHS Secretary Alex Azar. “Our strategy is beginning to produce results, thanks to so many Americans working on the ground, in their own communities, to turn the tide on this crisis.”
This funding will expand access to treatment that works, especially to medication-assisted treatment (MAT) with appropriate social supports.
“Strategies such as employing psychosocial supports, community recovery services and MAT using medicines approved by the FDA constitute the gold standard of treatment for opioid use disorders,” said Dr. Elinore F. McCance-Katz, Assistant Secretary for Mental Health and Substance Use.
Last summer, SAMHSA announced the first year of SOR funding. States and territories received funding based on a formula, with a 15 percent set-aside for the 10 states with the highest mortality rates related to drug overdose deaths.
Click here to read more.